foxo4 dri senolytic 2023 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells foxo4-dri peptide senolytic mouse study
foxo4 dri peptide senolytic mouse study 2023 Molecular modelling of the FOXO4 TP53 interaction to design FOXO4 DRI 10MG Alpha Omega Peptide Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice PMC FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





